Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Proposes More Stringent UDI Requirements For Some Device 'Convenience Kits'

This article was originally published in The Gray Sheet

Executive Summary

Under a draft guidance, more devices will require individual Unique Device Identification labels rather than being able to rely on a "convenience kit" exception in FDA's UDI regulation. The agency says surgical instruments packaged together for convenience but used and reprocessed for different procedures are too difficult to track without separately affixed or marked UDIs.

You may also be interested in...



Makers Of Medical Procedure Kits May Have To Slap A UDI On Their Contents Under Final FDA Guidance

The US agency's guidance says not every medical procedure kit is a so-called "convenience kit" whose contents can be exempted from Unique Device Identification labeling. The document also points out that devices used to replenish a first-aid kit should include UDI.

UDI Extensions: Convenience Kits, Repackaged Devices, Combo Products

Just a little more than two weeks before the next Unique Device Identification compliance date, US FDA has granted two-year extensions to three product categories that raise particular complications for UDI labeling.

Lannett Plans Seven Launches In Fiscal Year 2021

Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020. 

Topics

UsernamePublicRestriction

Register

SC143367

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel